Drexler Karen

SEC Form 4 insider trading activity

Drexler Karen has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including OM, RMD, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 5, 2026.

On the most recent filing, Drexler Karen is listed as Director at Outset Medical, Inc. Inside the rolling window, Drexler Karen reported no open-market purchases and 1 open-market sale totaling $7K in OM.

Companies traded

Other insiders at OM

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$7K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
OM
Drexler Karen
Sale$7KDec 2SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Drexler Karen made?

Drexler Karen has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including OM, RMD since 2025.

Which companies does Drexler Karen trade?

Drexler Karen has filed SEC Form 4 disclosures for 2 companies, including OM, RMD.

When was Drexler Karen's most recent SEC Form 4 filing?

Drexler Karen's most recent SEC Form 4 filing on Tracefour is dated Jun 5, 2026.

What is Drexler Karen's total buy and sell value in the current window?

Inside the rolling retention window, Drexler Karen bought $0 and sold $7K based on SEC Form 4 filings.

What was Drexler Karen's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 1,548 OM shares on 2025-12-01, worth $7K, per SEC Form 4 filings.